Clinical use of expanded prostate cancer index composite-based health-related quality of life outcomes after robot-assisted radical prostatectomy for localized prostate cancer

Prostate International - Tập 10 - Trang 62-67 - 2022
Kazuhiro Fukuda1, Satoru Muto1,2, Toshiyuki China1, Hiroki Koyasu1, Yasuhiro Noma1, Takeshi Ashizawa1, Hisashi Hirano1, Kosuke Kitamura1, Fumitaka Shimizu1, Masayoshi Nagata1, Shuji Isotani1, Shigeo Horie1,2
1Department of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan
2Department of Advanced Informatics for Genetic Disease, Juntendo University, Graduate School of Medicine, Tokyo, Japan

Tài liệu tham khảo

Wakao, 2018 Walz, 2007, A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer, J Clin Oncol, 25, 3576, 10.1200/JCO.2006.10.3820 Ficarra, 2012, Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy, Eur Urol, 62, 418, 10.1016/j.eururo.2012.05.046 Wei, 2002, Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer, J Clin Oncol, 20, 557, 10.1200/JCO.2002.20.2.557 Johansson, 2011, Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial, Lancet Oncol, 12, 891, 10.1016/S1470-2045(11)70162-0 Litwin, 1998, The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure, Med Care, 36, 1002, 10.1097/00005650-199807000-00007 Wei, 2000, Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer, Urology, 56, 899, 10.1016/S0090-4295(00)00858-X Rnic, 2013, Measuring symptoms in localized prostate cancer: a systematic review of assessment instruments, Prostate Cancer Prostatic Dis, 16, 111, 10.1038/pcan.2013.1 Dowrick, 2015, “We used a validated questionnaire”: what does this mean and is it an accurate statement in urologic research?, Urology, 85, 1304, 10.1016/j.urology.2015.01.046 Sanda, 2008, Quality of life and satisfaction with outcome among prostate-cancer survivors, N Engl J Med, 358, 1250, 10.1056/NEJMoa074311 Miyake, 2016, Prospective assessment of time-dependent changes in quality of life of Japanese patients with prostate cancer following robot-assisted radical prostatectomy, J Robot Surg, 10 D’ Amico, 1998, Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer, JAMA, 280, 969, 10.1001/jama.280.11.969 Kakehi, 2007, Health related quality of life in Japanese men with localized prostate cancer treated with current multiple modalities assessed by a newly developed Japanese version of the Expanded Prostate Cancer Index Composite, J Urol, 177, 1856 Levinson, 2011, Is a return to baseline sexual function possible? An analysis of sexual function outcomes following laparoscopic radical prostatectomy, World J Urol, 29, 29, 10.1007/s00345-010-0616-5 Chien, 2017, Health-related quality of life outcomes from a contemporary prostate cancer registry in a large diverse population, BJU Int, 120, 520, 10.1111/bju.13843 Pardo, 2010, Quality-of-Life impact of primary treatments for localized prostate cancer in patients without hormonal treatment, J Clin Oncol, 28, 4687, 10.1200/JCO.2009.25.3245 Yaxley, 2016, Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study, Lancet, 388, 1057, 10.1016/S0140-6736(16)30592-X Parker, 2011, Five year expanded prostate cancer index composite-based quality of life outcomes after prostatectomy for localized prostate cancer, BJU Int, 107, 585, 10.1111/j.1464-410X.2010.09579.x Litwin, 1999, Health related quality of life in older men without prostate cancer, J Urol, 161, 1180 Donovan, 2016, Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer, N Engl J Med, 375, 1425, 10.1056/NEJMoa1606221 Blanchard, 2018, Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort, BJU Int, 121, 540, 10.1111/bju.14021 Litwin, 2004, Bowel function and bother after treatment for early stage prostate cancer: a longitudinal quality of life analysis from CaPSURE, J Urol, 172, 515 Willis, 2012, Comparison of outcomes between pure laparoscopic vs robot-assisted laparoscopic radical prostatectomy: a study of comparative effectiveness based upon validated quality of life outcomes, BJU Int, 109, 898, 10.1111/j.1464-410X.2011.10551.x Walsh, 1982, Impotence following radical prostatectomy: insight into etiology and prevention, J Urol, 128, 492 Walz, 2010, A critical analysis of the current knowledge of surgical anatomy related to optimization of cancer control and preservation of continence and erection in candidates for radical prostatectomy, Eur Urol, 57, 179, 10.1016/j.eururo.2009.11.009 Zorn, 2007, Robotic-assisted laparoscopic prostatectomy: functional and pathologic outcomes with interfascial nerve preservation, Eur Urol, 51, 755, 10.1016/j.eururo.2006.10.019 Menon, 2005, Potency following robotic radical prostatectomy: a questionnaire based analysis of outcomes after conventional nerve sparing and prostatic fascia sparing techniques, J Urol, 174, 2291 Weng, 2017, Intrafascial versus interfascial nerve sparing in radical prostatectomy for localized prostate cancer: a systematic review and meta-analysis, Sci Rep, 7, 11454, 10.1038/s41598-017-11878-7 Norman, 2003, Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation, Med Care, 41, 582, 10.1097/01.MLR.0000062554.74615.4C Gay, 2013, Neoadjuvant androgen deprivation therapy (NADT) Leads to Immediate Impairment of Vitality/Hormonal and Sexual Quality of Life: Results of a Multi-Center, Prospective Study, Urology, 82, 1363, 10.1016/j.urology.2013.06.062 Revicki, 2008, Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes, J Clin Epidemiol, 61, 102, 10.1016/j.jclinepi.2007.03.012 Skolarus, 2015, Minimally important difference for the expanded prostate cancer index composite short form, Urology, 85, 101, 10.1016/j.urology.2014.08.044 Kerleau, 2016, Long-term quality of life among localised prostate cancer survivors: QALIPRO population-based study, Eur J Cancer, 63, 143, 10.1016/j.ejca.2016.05.020 Liu, 2019, Prostate cancer in Asia: design of a patient registry to inform real-world treatments, outcomes, and quality of life, Prostate Int, 7, 108, 10.1016/j.prnil.2018.12.001